Laird Norton Trust Company, LLC Athira Pharma, Inc. Transaction History
Laird Norton Trust Company, LLC
- $738 Million
- Q1 2024
A detailed history of Laird Norton Trust Company, LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Laird Norton Trust Company, LLC holds 147,309 shares of ATHA stock, worth $371,218. This represents 0.05% of its overall portfolio holdings.
Number of Shares
147,309
Previous 282,309
47.82%
Holding current value
$371,218
Previous $686,000
41.25%
% of portfolio
0.05%
Previous 0.08%
Shares
9 transactions
Others Institutions Holding ATHA
# of Institutions
83Shares Held
22.3MCall Options Held
77.1KPut Options Held
42.4K-
Perceptive Advisors LLC New York, NY5.4MShares$13.6 Million0.31% of portfolio
-
Baker Bros. Advisors LP New York, NY3.15MShares$7.95 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$4.12 Million0.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$3.76 Million2.38% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$3.76 Million0.26% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $95.3M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...